Open an account

Burning Rock Biotech

BNR · NASDAQ

$12.66+$0.37 (+3.01%)TodayMarket closed ·
Prev close $12.29

About BNR

Burning Rock Biotech Ltd. engages in the investment of medical fields. The firm operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.

Employees
667
Headquarters
Guangzhou, Guangdong
Listed
Jun 12, 2020
Sector
Health Care
Industry
Biotechnology
Website
brbiotech.com

BNR key statistics

Market cap
129.27M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
32.44K
Volume
15.62K
Open price
$12.03
High today
$13.78
Low today
$12.03
52 Week high
$41.72
52 Week low
$6.79

Burning Rock Biotech (BNR) at a glance

As of Oct 20, 2026, Burning Rock Biotech (BNR) shares are priced at $12.66, giving the company a market cap of 129.27M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $12.03 and $13.78. The current price is 5.2% above the day's low and 8.1% below its high.

Volume so far is 15.62K shares, below the average of 32.44K shares a day.

Over the past year Burning Rock Biotech has ranged from $6.79 to $41.72, and now sits 17% of the way up that range.

Burning Rock Biotech met or beat analyst EPS estimates in 1 of the last 8 quarters. In Q3 FY22 it reported -$22.30 per share against an estimate of -$23.74.

BNR earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 1 of the last 8 quarters, by 6.0% on average.

  1. Q4 FY20: reported -$15.10 per share against an estimate of -$12.52
  2. Q1 FY21: reported -$16.50 per share against an estimate of -$15.15
  3. Q2 FY21: reported -$19.60 per share against an estimate of -$15.05
  4. Q3 FY21: reported -$16.40 per share against an estimate of -$16.26
  5. Q4 FY21: reported -$24.00 per share against an estimate of -$17.07
  6. Q1 FY22: reported -$25.00 per share against an estimate of -$24.34
  7. Q2 FY22: reported -$25.00 per share against an estimate of -$24.24
  8. Q3 FY22: reported -$22.30 per share against an estimate of -$23.74

BNR news

  • Bamboo Works

    Why These High-Flying Stocks Came Back To Earth

  • Bamboo Works

    Burning Rock Stock Up 35%+ As Loss Narrows

  • 12 Health Care Stocks Moving In Monday's Intraday Session

  • 12 Health Care Stocks Moving In Monday's Intraday Session

  • Avi Kapoor

    Why Aehr Test Systems Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Similar companies

Companies in the same industry as Burning Rock Biotech

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.